APA

Helmschrott M., Beckendorf J., Akyol C., Ruhparwar A., Schmack B., Erbel C., Gleissner C. A., Akhavanpoor M., Ehlermann P., Bruckner T., Katus H. A. & Doesch A. O. (20150713). Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. : Drug design, development and therapy.

Chicago

Helmschrott Matthias, Beckendorf Jan, Akyol Ceylan, Ruhparwar Arjang, Schmack Bastian, Erbel Christian, Gleissner Christian A, Akhavanpoor Mohammadreza, Ehlermann Philipp, Bruckner Tom, Katus Hugo A and Doesch Andreas O. 20150713. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. : Drug design, development and therapy.

Harvard

Helmschrott M., Beckendorf J., Akyol C., Ruhparwar A., Schmack B., Erbel C., Gleissner C. A., Akhavanpoor M., Ehlermann P., Bruckner T., Katus H. A. and Doesch A. O. (20150713). Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. : Drug design, development and therapy.

MLA

Helmschrott Matthias, Beckendorf Jan, Akyol Ceylan, Ruhparwar Arjang, Schmack Bastian, Erbel Christian, Gleissner Christian A, Akhavanpoor Mohammadreza, Ehlermann Philipp, Bruckner Tom, Katus Hugo A and Doesch Andreas O. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. : Drug design, development and therapy. 20150713.